Springfield D S, Rosenberg A E, Mankin H J, Mindell E R
Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston.
Clin Orthop Relat Res. 1994 Dec(309):234-44.
The records and computer files of 32 patients treated at 1 institution for ossifying fibroma, fibrous dysplasia, osteofibrous dysplasia-like adamantinoma, or adamantinoma of the tibia were reviewed. Nineteen patients had their diagnosis changed, either because of a recurrence or through review of their histology. Six of the 9 patients who had a typical adamantinoma and 6 of the 10 patients who had an osteofibrous dysplasia-like adamantinoma had a diagnosis of 1 of the benign conditions before their adamantinoma was recognized. Only 6 patients actually had osteofibrous dysplasia. Three patients required a resection, but only 1 of the other 3 has been observed > 5 years. This review suggests that many patients with a diagnosis of fibrous dysplasia or osteofibrous dysplasia of the tibia actually have an adamantinoma, and that osteofibrous dysplasia is often a locally aggressive lesion that progresses until it is widely resected. In addition, osteofibrous dysplasia and adamantinoma appear to be related, and osteofibrous dysplasia may be a precursor of adamantinoma.
回顾了在一家机构接受治疗的32例骨化性纤维瘤、骨纤维结构不良、骨纤维异常增殖症样造釉细胞瘤或胫骨造釉细胞瘤患者的记录和计算机文件。19例患者的诊断发生了改变,原因要么是复发,要么是对其组织学进行复查。9例典型造釉细胞瘤患者中的6例以及10例骨纤维异常增殖症样造釉细胞瘤患者中的6例,在其造釉细胞瘤被确诊之前被诊断为一种良性疾病。实际上只有6例患者患有骨纤维异常增殖症。3例患者需要进行切除手术,但另外3例中只有1例被观察超过5年。该综述表明,许多诊断为胫骨骨纤维结构不良或骨纤维异常增殖症的患者实际上患有造釉细胞瘤,并且骨纤维异常增殖症通常是一种局部侵袭性病变,在广泛切除之前会持续进展。此外,骨纤维异常增殖症和造釉细胞瘤似乎有关联,骨纤维异常增殖症可能是造釉细胞瘤的前身。